Muhammet LİMON, Semral GÜLCEMAL, Dilek TEZCAN, Sema YILMAZ

Tekrarlayan hemoptizi ile başvuran Takayasu arteritli bir erkek olgu

Takayasu arteriti, etyolojisi tam olarak bilinmeyen aorta ve ana dalları olmak üzere büyük damarları etkileyen kronik granülomatöz büyük damar vaskülitidir. Takayasu arteritinin başlangıç yaşı 10-40 yaş olup %80-90 oranında kadınlarda görülür. Takayasu arteritinin klinik bulguları değişkendir. Takayasu arteriti kan akımı azalmasına bağlı baş dönmesi, kol ve bacaklarda ağrı, siyanoz, nabızsızlık ve nonspesifik konstitüsyonel semptomlar ile klinik bulgular verebilir. Takayasu arteritinin seyrinde alveolar hemoraji nadir olarak gözlenir. Bu olgu immünsüpresif tedavi ile akciğerde kaviter lezyonun progrese olması ve aspergilloma saptanması nedeniyle sunulmuştur.

A male patient with Takayasu's arteritis presenting with recurrent hemoptysis

Takayasu’s arteritis is a chronic granulomatous inflammatory large vessel vasculitis of unknown etiology. Takayasu’s arteritis primarily affects the aorta and its primary branches. Women are affected in 80 to 90 percent of cases, with an age of onset that is usually between 10 and 40 years. The onset of clinical symptoms in Takayasu’s arteritis are variably. Symptoms of vascular disease are cyanosis and/or pain in arms or legs, lightheadedness or other symptoms of reduced blood flow, or nonspecific constitutional symptoms. Pulmonary hemorrhage is rare in Takayasu’s arteritis. This case is presented because of the progress of cavitary lesion in the lung due to aspergilloma by immunosuppressive treatment.

Keywords:

Takayasu’s arteritis, hemoptysis, aspergilloma,

PDF

___

2.Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129.
2.Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J. 1977;93:94.
3. Sharma BK, Jain S, Kumari S. Systemic manifestations of Takayasu’s arteritis: expanding spectrum. Int J Cardiol. 1996;54:149-154
4. Kerr GS. Takayasu’s arteritis. Rheum Dis Clin North Am. 1995;21:1041-58.
5. Jain S, Kumari S, Ganguly NK, Sharma BK. Current status of Takayasu’s arteritis in India. Int J Cardiol. 1996;54:111-6.
6. Manganelli P, Fietta P, Carotti M, Pesci A, Salaffi F.. Respiratory system involvement in systemic vasculitides. .Clin Exp Rheumatol. 2006;24:48-59.
7. Nakabayashi K, Kurata N, Nangi N, Miyake H, Nagasawa T. Pulmonary artery involvement as first manifestation in three cases of Takayasu arteritis. Int J Cardiol. 1996;54:177-83.
8. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M et al. Takayasu arteritis. Ann Intern Med. 1994;120:919-29.
9. Michel BA, Arend WP, Hunder GG. Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis. J Rheumatol. 1996;23:106-11.
10. Yang PP, Yang YH, Kuang TG, Yang MF, Wang JF, Huang Q et al. Pulmonary cavities with Takayasu arteritis: report of 3 cases and literature review. Zhonghua Jie He He Hu Xi Za Zhi. 2018;41:787-92.
11. Neidhart B, Kosek R, Bachmann LM, Stey C. Exertional dyspnea as initial manifestation of Takayasu's arteritis--a case report and literature review. BMC Pulm Med. 2001;1:3.
12. Koyabu S, Isaka N, Yada T, Konishi T, Nakano T. Severe respiratory failure caused by recurrent pulmonary hemorrhage in Takayasu's arteritis. Chest. 1993;104:1905-6.
13. Savage BJ, Gupta RK, Angle J, Okusa MD. Takayasu arteritis presenting as a pulmonary-renal syndrome. 2003;325:275-81.
14. Alibaz-Oner F, Direskeneli H. Update on Takayasu's arteritis. Presse Med. 2015;44:e259-65..
15. Edwards KK, Lindsley HB, Lai CW, Van Veldhuizen PJ. Takayasu arteritis presenting as retinal and vertebrobasilar ischemia. J Rheumatol. 1989;16:1000- 2.
16. Cash JM, Engelbrecht JA. Takayasu's arteritis in western South Dakota. S D J Med. 1990;43:5-9.
17. Rodríguez-Hurtado FJ, Sabio JM, Lucena J, JiménezAlonso J. Ocular involvement in Takayasu's arteritis: response to cyclophosphamide therapy. Eur J Med Res. 2002;7:128-30.
18. Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. 2004;50:2296-304.
19. Comarmond C, Plaisier E, Dahan K, Mirault T, Emmerich J, Amoura Z et al. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.Autoimmun Rev. 2012;11:678-84.
20. Nishimoto N, Nakahara H, Yoshio-Hoshino N, Mima T. Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin6 receptor antibody. Arthritis Rheum. 2008;58:1197- 200.
21. Salvarani C, Magnani L, Catanoso M. Tosilizumab:a novel therapy for patients with large-vessel vasculitis. Rheumatology. 2012;51:151-6.